X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (845) 845
Publication (73) 73
Book Review (54) 54
Conference Proceeding (9) 9
Book Chapter (6) 6
Dissertation (6) 6
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (496) 496
index medicus (467) 467
neurosciences (387) 387
animals (351) 351
mice (309) 309
mice, transgenic (248) 248
humans (208) 208
alzheimers-disease (204) 204
disease models, animal (192) 192
app (178) 178
amyloid beta-protein precursor - genetics (157) 157
ps1 (155) 155
brain (150) 150
male (148) 148
alzheimer’s disease (145) 145
presenilin-1 - genetics (143) 143
app/ps1 mice (138) 138
transgenic mice (137) 137
alzheimer disease - genetics (133) 133
alzheimer disease - metabolism (133) 133
mice, inbred c57bl (120) 120
mouse model (120) 120
amyloid precursor protein (119) 119
app/ps1 transgenic mice (119) 119
alzheimer disease - pathology (117) 117
amyloid beta-peptides - metabolism (103) 103
app/ps1 (103) 103
analysis (97) 97
biochemistry & molecular biology (92) 92
hippocampus (92) 92
memory (91) 91
amyloid-beta (90) 90
female (90) 90
in-vivo (88) 88
genetic engineering (85) 85
neurology (84) 84
brain - metabolism (82) 82
amyloid beta-protein precursor - metabolism (79) 79
a-beta (77) 77
presenilin-1 (74) 74
cell biology (73) 73
presenilin 1 (72) 72
oxidative stress (70) 70
pharmacology & pharmacy (69) 69
amyloid beta-protein (66) 66
alzheimer disease - drug therapy (65) 65
pathology (63) 63
clinical neurology (62) 62
expression (60) 60
brain - pathology (57) 57
mental disorders (56) 56
rodents (56) 56
neurodegenerative diseases (55) 55
mild cognitive impairment (53) 53
proteins (53) 53
dementia (52) 52
neurons (52) 52
presenilin-1 - metabolism (52) 52
protein (52) 52
alzheimer disease - physiopathology (50) 50
alzheimers disease (49) 49
geriatrics & gerontology (48) 48
synaptic plasticity (48) 48
β-amyloid (47) 47
hippocampus - metabolism (46) 46
long-term potentiation (46) 46
cognition (45) 45
amyloid (44) 44
inflammation (44) 44
membrane proteins - genetics (43) 43
apoptosis (42) 42
memory deficits (42) 42
mutation (42) 42
neurodegeneration (42) 42
amyloid-β (41) 41
cognitive ability (41) 41
immunohistochemistry (41) 41
neuroinflammation (40) 40
precursor protein (40) 40
brain - drug effects (39) 39
ps1 mice (39) 39
rats (39) 39
tau (39) 39
beta-amyloid (38) 38
cognitive impairment (38) 38
membrane proteins - metabolism (38) 38
research (38) 38
aging (36) 36
physiological aspects (36) 36
activation (35) 35
nervous system (35) 35
alzheimer disease (34) 34
article (34) 34
deposition (34) 34
animal models (33) 33
cells (33) 33
microglia (32) 32
alzheimer disease - psychology (31) 31
app/ps1 transgenic mouse (31) 31
autophagy (31) 31
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroimmunology, ISSN 0165-5728, 06/2018, Volume 319, pp. 80 - 92
effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on behavioral and pathological outcomes in Alzheimer's disease (AD) and non-transgenic... 
Synaptophysin | Calbindin | APP/PS1 mice | Tregs | Doublecortin | Aβ plaques | Amyloidosis | Cognitive function | Hippocampus | cognitive function | calbindin | synaptophysin | APP | doublecortin | amyloidosis | hippocampus | PS1 mice
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2015, Volume 36, Issue 12, pp. 3187 - 3199
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 05/2019, Volume 330, pp. 108 - 115
Mounting evidence has shown that inflammation might drive Alzheimer's disease (AD) pathology and contribute to its exacerbation. Previous studies have... 
Learning | Atorvastatin | Indomethacin | Alzheimer's disease | Memory | PrP-hAβPPswe/PS1ΔE9 transgenic mouse | PrP-hAβPPswe/PS1 | transgenic mouse
Journal Article
BBA - Molecular Basis of Disease, ISSN 0925-4439, 09/2016, Volume 1862, Issue 9, pp. 1786 - 1800
Alzheimer's disease (AD) is currently one of the most common neurodegenerative disorders worldwide. To date, no cure has been developed for AD, and some... 
Neuroprotection | Alzheimer's disease | Cyanidin 3-O-β-glucopyranoside | APPswe/PS1ΔE9 mice | PPARγ | Aβ25–35 | APP | mice | PS1
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 11/2018, Volume 353, pp. 114 - 123
Early Alzheimer's disease (AD) and depression share many symptoms, but the underlying mechanisms are not clear. Therefore, characterizing the shared and... 
APP | Amyloid beta | Depression | Anxiety | mice | Alzheimer's disease | Hippocampus | PS1
Journal Article
Brain Research, ISSN 0006-8993, 11/2018, Volume 1698, pp. 114 - 120
Transgenic animal models of Alzheimer’s disease (AD) can mimic pathological and behavioral changes occurring in AD patients, and are usually viewed as the... 
DTI | ASL | APP/PS1 transgenic mice | Alzheimer’s disease | MRI | MRS
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 03/2016, Volume 51, Issue 2, pp. 489 - 500
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2019, Volume 301, pp. 62 - 75
Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's disease (AD) but its inherent instability limits bioavailability and... 
Epigallocatechin gallate | PLGA-PEG | Polymeric nanoparticles | APP/PS1 mice | Alzheimer's disease | EGCG | EGGG | EARLY-DIAGNOSIS | PROTEIN | BLOOD-BRAIN-BARRIER | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | TEA | COGNITIVE DECLINE | PEG | PLGA-NANOPARTICLES | (-)-EPIGALLOCATECHIN GALLATE | PHARMACOLOGY & PHARMACY | Dextran | Nanoparticles | Catechin | Analysis | Vitamin C | Health aspects | Polyols | Nanotechnology | APP | WT, wild-type | Aβ, amyloid-β | GFAP, glial fibrillary acidic protein | PS1 mice | PS1dE9 | TNFα, tumor necrosis factor α | AA NPs-Rho, EGCG | SYN, Synaptophysin | FITC-dextran, Fluorescein isothiocyanate-dextran | IL-6, interleukin 6 | BBB, blood-brain barrier | HPLC, high performance liquid chromatography | PDI, polydispersity index | EGCG, epigallocatechin-3-gallate | Rho, Rhodamine 110 | PEG, Polyethylene glycol | FTIR, Fourier transform infrared spectroscopy | ZP, zeta potential | BMVECs, brain microvascular endothelial cells | NPs, nanoparticles | EE, encapsulation efficiency | XRD, X ray diffraction | AA NPs, dual-drug loading PEGylated PLGA nanoparticles of EGCG and AA | PLGA, poly(lactic-co-glycolic acid) | MWM, Morris Water Maze | Zav, average particle size | TEER, transendothelial electric resistance | AA, ascorbic acid | i.p., intraperitoneal | PS1, APPswe | iNOS, inducible nitric oxide synthase | AA NPs covalently labelled with Rhodamine 110 | PFA, paraformaldehyde | ThS, Thioflavin-S | NOR, Novel Object Recognition
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 05/2013, Volume 245, pp. 120 - 127
► There are inconsistencies in the behavioural phenotype of APPxPS1 transgenic mice. ► Male APPxPS1 mice showed task-dependent hyperlocomotion and increased... 
Sensorimotor gating | Cheeseboard | Behaviour | Alzheimer's disease | Social recognition memory | Transgenic APPSwe/PS1ΔE9 mice | PS1ΔE9 mice | Transgenic APP
Journal Article
Molecular Brain, ISSN 1756-6606, 05/2014, Volume 7, Issue 1, pp. 40 - 40
Journal Article
ASN Neuro, ISSN 1759-0914, 9/2016, Volume 8, Issue 5, p. 175909141667097
Histochemical methods of detecting iron in the rodent brain result mainly in the labeling of oligodendrocytes, but as all cells utilize iron, this observation... 
iron | plaque | ferric | Alzheimer’s disease | histochemistry | APP/PS1
Journal Article
NeuroReport, ISSN 0959-4965, 07/2018, Volume 29, Issue 10, pp. 833 - 838
Excessive extracellular deposition of amyloid-β-peptide (Aβ) in the brain is a pathological hallmark of Alzheimer’s disease (AD). Oxidative stress is... 
amyloid-β peptides | tricyclodecan-9-yl-xanthogenate | Alzheimer's disease | β-secretase 1 | oxidative stress | AβPP/PS1 mouse | Index Medicus | Alzheimer’s disease | Cellular, Molecular and Developmental Neuroscience | PS1 mouse | AβPP
Journal Article